U.S.-German firms end drug venture

Article Abstract:

Cambridge NeuroScience Inc. and Boehringer Ingelheim GmbH terminated their venture to develop Cerestat, a drug for stroke and traumatic brain injury. Cambridge, which believes that Cerestat is effective, inked its collaboration with Boehringer in 1995 amid optimism that the drug would help prevent the death of brain cells by blocking calcium intake, which be toxic. The deal required Boehringer to finance 75% of the drug development project in exchange for the right to market Cerestat in Europe and co-market in the US.

Comment:

Terminates its venture w/ Cambridge NeuroScience Inc to develop Cerestat, a drug for stroke & traumatic brain injury

Product development, Germany, Pharmaceutical Preparation Manufacturing, Central Nervous System Prep, Central nervous system agents, Boehringer Ingelheim GmbH, Cambridge NeuroScience Inc.

---

Ben & Jerry's ends Dreyer's link and allies with Diageo unit

Article Abstract:

Ben & Jerry's announced that it is terminating its 12-year relationship with Dreyer's. Under the relationship, Dreyer's sold and distributed Ben & Jerry's ice cream confections. The company made its decision because it was angered by a unsolicited takeover bid from Dreyer's. Ben & Jerry's also feared that it was losing control of its future. The firm said that Diageo PLC's Haagen-Dazs would replace Dreyer's.

Comment:

Ben & Jerry's to terminate 12-year distribution relationship with Dreyer's; names Diageo to replace Dreyer's

Strategic alliances, Ice Cream & Frozen Desserts, Ice Cream and Frozen Dessert Manufacturing, Frozen desserts, Dreyer's Grand Ice Cream Inc., Ben & Jerry's Homemade Inc., Diageo P.L.C.

---

Boston Scientific names new CEO, winning applause

Article Abstract:

Boston Scientific Corp. appointed James R. Tobin as its new president and chief executive officer. The appointment pleasantly surprised the company's investors. Mr. Tobin is highly-regarded. His appointment at Boston Scientific reflects confidence in the company after it experienced a difficult 1998. Boston Scientific provides medical devices that are utilized in minimally invasive surgery.

Comment:

Appoints James R. Tobin as new president and chief executive officer

Executive changes & profiles, Medical Instruments and Supplies, Medical Equipment and Supplies Manufacturing, Medical Instruments & Supplies, Officials and employees, Appointments, resignations and dismissals, Abstract, Medical equipment and supplies industry, Medical equipment industry, Boston Scientific Corp.

Similar abstracts:

• Abstracts: The German market for dishwashing detergents: market shares: household cleaning agents: manufacturers'
• Abstracts: The German market for dishwashing detergents: distribution: private label: household cleaning agents. The German market for dishwashing detergents: distribution: retail: household cleaning agents
• Abstracts: Nicoderm first off the mark with ads. Mapping out opportunities
• Abstracts: Astra writes a prescription for future. Roche Holding's net income rises 3%
• Abstracts: Hong Kong firms turn to airports in Shenzhen, Macau. CyberWorks stakes out Asia

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.